ranolazine has been researched along with Angina at Rest in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blankenberg, S; Deutscher, N; Diermann, N; Friedrich, FW; Radziwolek, L; Schwemer, TF; Sehner, S | 1 |
| Mittal, SR | 1 |
| Guo, J; Im, K; Morrow, DA; Patel, RB; Scirica, BM; Tannenbaum, S; Viana-Tejedor, A | 1 |
| Arnold, SV; Braunwald, E; Cohen, DJ; Lei, Y; Mahoney, EM; Morrow, DA; Scirica, BM; Wang, K | 1 |
| Hochman, JS; McCabe, CH; Mega, JL; Merlini, P; Morrow, DA; Murphy, SA; Scirica, BM; Sloan, S | 1 |
| Reddy, BM; Schwartzbard, AZ; Weintraub, HS | 1 |
| Defelice, A; Girton, J; Glasser, SP; Hung, J; Lawrence, J; Lipicky, RJ; Mangano, D; Obot, E; Targum, S; Throckmorton, D; Willard, J | 1 |
| Braunwald, E; Karwatowska-Prokopczuk, E; McCabe, CH; Morrow, DA; Scirica, BM; Skene, A | 1 |
| SoRelle, R | 1 |
2 review(s) available for ranolazine and Angina at Rest
| Article | Year |
|---|---|
Ranolazine: a new approach to treating an old problem.
Topics: Acetanilides; Angina Pectoris; Angina, Unstable; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Evidence-Based Medicine; Heart Diseases; Heart Failure, Diastolic; Humans; Myocardial Infarction; Piperazines; Practice Guidelines as Topic; Ranolazine; Sodium Channel Blockers; Treatment Outcome | 2010 |
Is randomization to placebo safe? Risk in placebo-controlled angina trials: angina risk meta-analysis.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Cardiovascular Diseases; Drug Approval; Enzyme Inhibitors; Female; Hospitalization; Humans; Male; Medical Records; Middle Aged; Nitrates; Observer Variation; Patient Dropouts; Patient Safety; Piperazines; Placebos; Randomized Controlled Trials as Topic; Ranolazine; Risk Assessment; Risk Factors; Treatment Failure | 2011 |
5 trial(s) available for ranolazine and Angina at Rest
| Article | Year |
|---|---|
Effect of Ranolazine on Ischemic Myocardium IN Patients With Acute Cardiac Ischemia (RIMINI-Trial): A Randomized Controlled Pilot Trial.
Topics: Adult; Aged; Angina, Unstable; Coronary Circulation; Feasibility Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Proof of Concept Study; Ranolazine; Recovery of Function; Sodium Channel Blockers; Time Factors; Treatment Outcome; Ventricular Function, Left | 2019 |
Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36.
Topics: Aged; Angina, Unstable; Arrhythmias, Cardiac; Cardiovascular Agents; Electrocardiography; Female; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Potassium; Ranolazine | 2017 |
Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.
Topics: Acetanilides; Acute Coronary Syndrome; Aged; Angina, Unstable; Disease Progression; Double-Blind Method; Dyspnea; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Quality of Life; Ranolazine; Surveys and Questionnaires | 2008 |
Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36).
Topics: Acetanilides; Acute Coronary Syndrome; Aged; Angina, Unstable; Death; Electrocardiography; Enzyme Inhibitors; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Piperazines; Prospective Studies; Ranolazine; Risk Factors; Sex Characteristics; Sex Distribution; Surveys and Questionnaires; Thrombolytic Therapy | 2010 |
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.
Topics: Acetanilides; Acute Disease; Aged; Angina, Unstable; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Piperazines; Ranolazine; Syndrome | 2006 |
2 other study(ies) available for ranolazine and Angina at Rest
| Article | Year |
|---|---|
Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine.
Topics: Acetanilides; Aged, 80 and over; Angina, Unstable; Benzazepines; Bradycardia; Diltiazem; Drug Interactions; Drug Substitution; Drug Therapy, Combination; Electrocardiography; Female; Humans; Ivabradine; Long QT Syndrome; Piperazines; Ranolazine; Torsades de Pointes | 2014 |
Cardiovascular news.
Topics: Acetanilides; Angina, Unstable; Anti-Arrhythmia Agents; Calcium Channel Blockers; Coronary Disease; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrinolytic Agents; Fondaparinux; Humans; Hydantoins; Imidazoles; Imidazolidines; Multicenter Studies as Topic; Myocardial Infarction; Nicorandil; Piperazines; Polysaccharides; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome | 2001 |